Lily Scourfield
@lilyscourfield.bsky.social
CT2 Anaesthetics NW London | MSc Trauma Sciences Blizard Institute, QMUL |Previous AFP King’s College London | She/her 🏴
https://www.researchgate.net/profile/Lily-Scourfield
https://www.researchgate.net/profile/Lily-Scourfield
Delighted to have achieved my FUSIC heart accreditation @ics-updates.bsky.social 🎉 grateful for mentors at Charing Cross whom I couldn’t have done this without! A useful skill to have and looking forward to continuing my echo learning!🫀
May 13, 2025 at 8:28 PM
Delighted to have achieved my FUSIC heart accreditation @ics-updates.bsky.social 🎉 grateful for mentors at Charing Cross whom I couldn’t have done this without! A useful skill to have and looking forward to continuing my echo learning!🫀
Pleased to see my full review has been published in this month’s issue of Haematologica @elsevierconnect.bsky.social and delighted it has made the front cover! A welcome surprise to offset the pre-night shift nerves 🩸🤓 haematologica.org/article/view...
February 24, 2025 at 9:27 PM
Pleased to see my full review has been published in this month’s issue of Haematologica @elsevierconnect.bsky.social and delighted it has made the front cover! A welcome surprise to offset the pre-night shift nerves 🩸🤓 haematologica.org/article/view...
Reposted by Lily Scourfield
Two patients with refractory myeloma who had excellent antitumor responses to cilta-cel CAR T-cell therapy later had T-cell lymphomas that contained the lentivirus construct used to generate the CAR T-cell product. Brief Report on the CARTITUDE-4 trial: nej.md/4gA6G27
#MedSky #Hematology
#MedSky #Hematology
CAR+ T-Cell Lymphoma after Cilta-cel Therapy for Relapsed or Refractory Myeloma | NEJM
We describe two patients in whom malignant monoclonal T-cell lymphoproliferation developed after administration of chimeric antigen receptor (CAR) T-cell therapy with ciltacabtagene autoleucel (cil...
nej.md
February 12, 2025 at 10:30 PM
Two patients with refractory myeloma who had excellent antitumor responses to cilta-cel CAR T-cell therapy later had T-cell lymphomas that contained the lentivirus construct used to generate the CAR T-cell product. Brief Report on the CARTITUDE-4 trial: nej.md/4gA6G27
#MedSky #Hematology
#MedSky #Hematology
And that’s the first 6 months of anaesthetics done! 1 IAC, 66 intubations, 103 cannulas, over 200 cases and countless cups of coffee later I’m so glad I’ve chosen this specialty! A steep learning curve but I’m looking forward to rotating to ICM and working on my FUSIC heart logbook!
February 4, 2025 at 8:13 PM
And that’s the first 6 months of anaesthetics done! 1 IAC, 66 intubations, 103 cannulas, over 200 cases and countless cups of coffee later I’m so glad I’ve chosen this specialty! A steep learning curve but I’m looking forward to rotating to ICM and working on my FUSIC heart logbook!
Reposted by Lily Scourfield
Want to learn more about the management of CAR-T therapy toxicities?
#AnSky #ICUSky #MedSky #criticalcare
buff.ly/4jnHoXE
#AnSky #ICUSky #MedSky #criticalcare
buff.ly/4jnHoXE
January 22, 2025 at 1:00 PM
Want to learn more about the management of CAR-T therapy toxicities?
#AnSky #ICUSky #MedSky #criticalcare
buff.ly/4jnHoXE
#AnSky #ICUSky #MedSky #criticalcare
buff.ly/4jnHoXE